Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-26-007502·Immunocore Holdings plc
Schedule 13G ownership disclosure
IMMUNOCORE HOLDINGS PLC
Ordinary Shares, nominal value 0.002 GBP per share · CUSIP: 45258D105
Event date: 2026-11-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 2,720,043.00 · Class: 5.2%
- Point72 Capital Advisors, Inc.
Shares: 2,720,043.00 · Class: 5.2%
- Steven A. Cohen
Shares: 2,720,043.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-007502
- Form type
- SCHEDULE 13G
- Filer
- Immunocore Holdings plc
- CIK
- CIK 1671927
- Filed
- Nov 09, 2026
- Reporting period
- Nov 06, 2026
- Description
- Schedule 13G beneficial ownership